VALN News and Press, Valneva SE From 05/19/22

Several days after experiencing a pleasant share price pop on good regulatory news, Dynavax (NASDAQ: DVAX) repeated the feat on Thursday. An important partner for the company reported an encouraging development that morning, also in the regulatory sphere. Investors lapped up the fre...

Valneva (NASDAQ:VALN) (OTCPK:INRLF) said the European Medicines Agency (EMA) accepted its marketing authorization application (MAA) for COVID-19 vaccine VLA2001. The French company's stock rose ~9% to €10.94 on May 19 on the Euronext Paris where it trades under the ticker VLA. The...

Although optimists currently believe we're getting past the worst of the coronavirus pandemic, Dynavax Technologies (NASDAQ: DVAX) shares saw a lift Monday on positive vaccine news. A popular coronavirus stock in the worst days of the outbreak, an important business partner of the c...

Wall Street finished with a mixed performance on Monday, as the major averages wound their way through another uncertain session. The S&P 500 and Nasdaq lost ground, while the Dow posted a fractional gain. While most market segments ended the day lower, the energy sector remained a source...

Gainers: Data Storage Corporation (DTST) +40%. Indonesia Energy Corporation (INDO) +30%. Harpoon Therapeutics (HARP) +28%. Pulse Biosciences (PLSE) +24%. Praxis Precision Medicines (PRAX) +24%. Xeris Biopharma Holdings (XERS) +24%. Griffon Corporation (GFF) +22%. New Concept Energy (GBR) +20%...

Gainers: Harpoon Therapeutics (HARP) +18%. Grove (GRVI) +11%. NanoViricides NNVC +11%. Travere Therapeutics TVTX +9%. Compass Therapeutics (CMPX) +4%. Losers: Chimerix CMRX -58%. Eliem Therapeutics ELYM -29%. Humacyte (HUMA) -20%. Va...

Valneva (OTCPK:INRLF) (NASDAQ:VALN) said the United Arab Emirates (UAE) granted emergency use authorization to its inactivated, adjuvanted COVID-19 vaccine VLA2001. However, the French company's stock fell ~20% to €9.50 on May 16 on the Euronext Paris (Ticker: VLA) as the Eur...

Valneva (NASDAQ:VALN) (OTCPK:INRLF) said the European Commission (EC) intends to terminate its advance purchase agreement (APA) for the company's inactivated whole-virus COVID-19 vaccine VLA2001. The French company's stock fell ~20% to €9.50 on May 16 on the Euronext Par...

Valneva SE (VALN) Q1 2022 Earnings Conference Call May 5, 2022 10:00 AM ET Company Participants Thomas Lingelbach - Chief Executive Officer Peter Buhler - Chief Financial Officer Franck Grimaud - Chief Business Officer Conference Call Participants Samir Devani - Rx Securities Maury Raycroft -...

The following slide deck was published by Valneva SE in conjunction with their 2022 Q1 earnings call. For further details see: Valneva SE 2022 Q1 - Results - Earnings Call Presentation